share_log

CNS Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Cortice Biosciences, Inc.

SEC ·  Aug 7 04:58
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more